Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014545882> ?p ?o ?g. }
- W3014545882 endingPage "868" @default.
- W3014545882 startingPage "868" @default.
- W3014545882 abstract "Breast cancer (BCa) cells disseminating to the bone can remain dormant and resistant to treatments for many years until relapsing as bone metastases. The tyrosine kinase receptor TIE2 induces the dormancy of hematopoietic stem cells, and could also induce the dormancy of BCa cells. However, TIE2 is also a target for anti-angiogenic treatments in ongoing clinical trials, and its inhibition could then restart the proliferation of dormant BCa cells in bone. In this study, we used a combination of patient data, in vitro, and in vivo models to investigate the effect of TIE2 in the dormancy of bone metastases. In BCa patients, we found that a higher TIE2 expression is associated with an increased time to metastases and survival. In vitro, TIE2 decreased cell proliferation as it increased the expression of cyclin-dependent kinase inhibitors CDKN1A and CDKN1B and arrested cells in the G0/G1 phase. Expression of TIE2 also increased the resistance to the chemotherapeutic 5-Fluorouracil. In mice, TIE2 expression reduced tumor growth and the formation of osteolytic bone metastasis. Together, these results show that TIE2 is sufficient to induce dormancy in vitro and in vivo, and could be a useful prognostic marker for patients. Our data also suggest being cautious when using TIE2 inhibitors in the clinic, as they could awaken dormant disseminated tumor cells." @default.
- W3014545882 created "2020-04-10" @default.
- W3014545882 creator A5005852735 @default.
- W3014545882 creator A5009212679 @default.
- W3014545882 creator A5013948305 @default.
- W3014545882 creator A5018114039 @default.
- W3014545882 creator A5046230249 @default.
- W3014545882 creator A5050680383 @default.
- W3014545882 creator A5063454008 @default.
- W3014545882 creator A5091456694 @default.
- W3014545882 date "2020-04-03" @default.
- W3014545882 modified "2023-10-13" @default.
- W3014545882 title "TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases" @default.
- W3014545882 cites W1482226454 @default.
- W3014545882 cites W1607267312 @default.
- W3014545882 cites W1668963162 @default.
- W3014545882 cites W1761343402 @default.
- W3014545882 cites W1867790738 @default.
- W3014545882 cites W1944152380 @default.
- W3014545882 cites W1972124518 @default.
- W3014545882 cites W1976173969 @default.
- W3014545882 cites W1982846895 @default.
- W3014545882 cites W1984328540 @default.
- W3014545882 cites W1993497779 @default.
- W3014545882 cites W2005895632 @default.
- W3014545882 cites W2006986876 @default.
- W3014545882 cites W2021710007 @default.
- W3014545882 cites W2025176940 @default.
- W3014545882 cites W2029938510 @default.
- W3014545882 cites W2031018864 @default.
- W3014545882 cites W2034355448 @default.
- W3014545882 cites W2036452381 @default.
- W3014545882 cites W2044702943 @default.
- W3014545882 cites W2053970131 @default.
- W3014545882 cites W2060610551 @default.
- W3014545882 cites W2068503417 @default.
- W3014545882 cites W2096079397 @default.
- W3014545882 cites W2096767066 @default.
- W3014545882 cites W2097255042 @default.
- W3014545882 cites W2098412103 @default.
- W3014545882 cites W2098593935 @default.
- W3014545882 cites W2100864427 @default.
- W3014545882 cites W2106738771 @default.
- W3014545882 cites W2118413367 @default.
- W3014545882 cites W2125868380 @default.
- W3014545882 cites W2131994307 @default.
- W3014545882 cites W2139522545 @default.
- W3014545882 cites W2140090725 @default.
- W3014545882 cites W2150533948 @default.
- W3014545882 cites W2158093070 @default.
- W3014545882 cites W2159303972 @default.
- W3014545882 cites W2161962336 @default.
- W3014545882 cites W2166889065 @default.
- W3014545882 cites W2167371528 @default.
- W3014545882 cites W2168202400 @default.
- W3014545882 cites W2170527434 @default.
- W3014545882 cites W2259802687 @default.
- W3014545882 cites W2276433233 @default.
- W3014545882 cites W2312265744 @default.
- W3014545882 cites W2415870562 @default.
- W3014545882 cites W2464001628 @default.
- W3014545882 cites W2511181429 @default.
- W3014545882 cites W2580755748 @default.
- W3014545882 cites W2745510155 @default.
- W3014545882 cites W2765631687 @default.
- W3014545882 cites W2887080950 @default.
- W3014545882 cites W2895926103 @default.
- W3014545882 cites W2897235350 @default.
- W3014545882 cites W2954433278 @default.
- W3014545882 cites W93315677 @default.
- W3014545882 doi "https://doi.org/10.3390/cancers12040868" @default.
- W3014545882 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7226250" @default.
- W3014545882 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32260072" @default.
- W3014545882 hasPublicationYear "2020" @default.
- W3014545882 type Work @default.
- W3014545882 sameAs 3014545882 @default.
- W3014545882 citedByCount "7" @default.
- W3014545882 countsByYear W30145458822021 @default.
- W3014545882 countsByYear W30145458822022 @default.
- W3014545882 countsByYear W30145458822023 @default.
- W3014545882 crossrefType "journal-article" @default.
- W3014545882 hasAuthorship W3014545882A5005852735 @default.
- W3014545882 hasAuthorship W3014545882A5009212679 @default.
- W3014545882 hasAuthorship W3014545882A5013948305 @default.
- W3014545882 hasAuthorship W3014545882A5018114039 @default.
- W3014545882 hasAuthorship W3014545882A5046230249 @default.
- W3014545882 hasAuthorship W3014545882A5050680383 @default.
- W3014545882 hasAuthorship W3014545882A5063454008 @default.
- W3014545882 hasAuthorship W3014545882A5091456694 @default.
- W3014545882 hasBestOaLocation W30145458821 @default.
- W3014545882 hasConcept C100701293 @default.
- W3014545882 hasConcept C101544691 @default.
- W3014545882 hasConcept C121608353 @default.
- W3014545882 hasConcept C126322002 @default.
- W3014545882 hasConcept C142724271 @default.
- W3014545882 hasConcept C150903083 @default.
- W3014545882 hasConcept C170493617 @default.
- W3014545882 hasConcept C207001950 @default.